Inactive Instrument
Albany Molecular Research, Inc. Stock
Stocks
US0124231095
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
Philip Macnabb
CEO | Chief Executive Officer | - | 2023-02-28 |
Gerald Auer
DFI | Director of Finance/CFO | - | 2023-12-31 |
John Valley
CTO | Chief Tech/Sci/R&D Officer | - | 2019-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +0.09% | - | - | 0 | |
| -6.60% | -8.56% | +42.79% | +64.16% | 68.98B | |
| -4.09% | -0.11% | +2.31% | +54.81% | 53.15B | |
| +0.03% | +5.56% | +10.18% | +41.75% | 50.83B | |
| -1.53% | +2.70% | +29.72% | +34.13% | 44.61B | |
| -1.34% | +4.12% | +16.05% | +112.18% | 42.53B | |
| -5.97% | -6.22% | +258.21% | +421.57% | 40.57B | |
| +6.53% | +8.02% | +15.74% | +53.94% | 30.95B | |
| -0.90% | -10.49% | +31.48% | -1.63% | 25.44B | |
| -2.76% | -9.54% | -16.53% | -9.55% | 22.66B | |
| Average | -1.66% | -0.38% | +43.33% | +85.71% | 42.19B | |
| Weighted average by Cap. | -2.43% | -0.10% | +44.74% | +90.25% |
